Endocyte
Headquarters
3000 Kent Avenue
West Lafayette
Indiana
47906
United States
171 articles about Endocyte
-
Endocyte, Inc. to Present Multiple Abstracts at the 100th Annual Meeting of the American Association for Cancer Research
4/17/2009
-
Endocyte, Inc. Announces Positive Interim Results from Phase II Clinical Trial of EC145 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
3/25/2009
-
Endocyte, Inc. Announces Positive Interim Results from Phase II Clinical Trial of EC145 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
3/24/2009
-
Endocyte, Inc. Begins Phase II Clinical Trial of EC145 For Treatment of Women with Ovarian Cancer
2/19/2009
-
Endocyte Awarded Patent For Vitamin-Targeted Imaging Agent
11/29/2006
-
Michael A. Sherman Joins Endocyte As CFO
10/11/2006
-
Keith E. Brauer Joins Endocyte Board Of Directors
9/12/2006
-
Endocyte Announces Patent Issued To Enhance Cancer Targeting In Immunotherapy
5/17/2006
-
Endocyte Begins Phase 1 Trial Of EC145 For Treatment Of Refractory Solid Tumors
4/20/2006
-
Endocyte Signs Agreement With Bristol-Myers Squibb Company To Develop And Commercialize Folate-Targeted Chemotherapeutic Agents
1/5/2006
-
Endocyte Receives Notice Of A U.S. Patent Allowance For A Targeted Immunotherapy Treatment
11/2/2005